Role of statins in chronic liver disease
Journal Title: Journal of Clinical Hepatology - Year 2024, Vol 40, Issue 10
Abstract
Chronic liver disease is the “devil’s trilogy” in which the liver progresses from inflammation and fibrosis to liver cirrhosis and hepatocellular carcinoma, which poses a great challenge for hepatologists worldwide. Statins have played a significant role in the treatment of cardiovascular diseases and hyperlipidemia since their introduction, and in recent years, they have also demonstrated the potential to improve hepatic steatosis, exert an anti-inflammatory effect, regulate the phenotype of hepatic stellate cells, reduce portal venous pressure, and improve hepatic microcirculation in chronic liver disease. This article reviews the latest advances in the basic and clinical studies of statins in chronic liver disease, in order to provide new insights into the research, prevention, and treatment of chronic liver disease.
Authors and Affiliations
Xikun YANG, Hui LI, Zijian ZENG, Xuan WU, Kaixin WANG
Experience in eliminating the mother-to-child transmission of hepatitis B virus in China
Reducing the mother-to-child transmission of hepatitis B virus (HBV) is crucial for achieving HBV elimination. Launched in July 2015 at the Great Hall of the People in Beijing, China, the “Zero Hepatitis B Mother-to-...
Efficacy of transjugular intrahepatic portosystemic shunt in treatment of hepatocellular carcinoma comorbid with esophagogastric variceal bleeding
[Objective] To investigate the efficacy of transjugular intrahepatic portosystemic shunt (TIPS) in preventing rebleeding in patients with hepatocellular carcinoma (HCC) comorbid with esophagogastric variceal bleeding...
An excerpt of American College of Gastroenterology guidelines: Management of acute pancreatitis (2024)
The American College Gastroenterology (ACG) recently released the 2024 edition of Guidelines for the management of acute pancreatitis. The guidelines first discuss the diagnosis, etiology, severity, and early manage...
Clinical efficacy of liver venous deprivation versus portal vein embolization in treatment of liver cancer with insufficient residual liver volume: A Meta-analysis
[Objective] To systematically evaluate the efficacy and prognosis of liver venous deprivation (LVD) versus portal vein embolization (PVE) in the treatment of hepatic malignancies with insufficient residual liver volu...
Effect of interleukin-22 on hepatic stellate cell activation and its mechanism
[Objective] To investigate the effect of interleukin-22 (IL-22) on the activation of hepatic stellate cells (HSCs) and its mechanism. [Methods] The human HSC LX-2 cells were selected for the study, and the LX-2 cell...